By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Small-cap stock below 100: Pharma stock in focus after Q4 results 2025, final dividend for FY25 | Stock Market News
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Business > Small-cap stock below 100: Pharma stock in focus after Q4 results 2025, final dividend for FY25 | Stock Market News
Business

Small-cap stock below 100: Pharma stock in focus after Q4 results 2025, final dividend for FY25 | Stock Market News

Last updated: May 31, 2025 8:01 pm
1 year ago
Share
SHARE


Small-cap stock below 100: Sigachi Industries Ltd announced its January-March quarter results for fiscal 2024-25 (Q4FY25) on Saturday, May 31, reporting a net profit of ₹697.78 lakh compared to ₹1,172.93 lakh in the corresponding period last year.

The Hyderabad-based BSE Smallcap company said that its reported a consolidated net profit of ₹22.67 crore in Q4, up nearly 7 per cent on YoY basis. The company had earned a net profit of ₹15.17 crore in the same quarter of the previous fiscal.

The company’s revenue from operations surged by 23 per cent to ₹128.2 crore versus ₹104.1 crore reported in the corresponding quarter of the FY 2024. Its expenses in the reporting quarter increased to ₹107.7 crore from ₹94.1 crore in March 2024 quarter.

Sigachi Industries Limited is an India-based company that manufactures primarily microcrystalline cellulose . The Company is engaged in manufacturing cellulose-based excipients for finished dosages in the pharmaceutical industry.



Source link

You Might Also Like

Week Ahead: Wall Street eyes US jobs data, SpaceX debut earnings and Disney results | Stock Market News

Access Denied

Access Denied

Access Denied

Sebi order against Zee likely to delay planned ₹3,143-crore fundraise | Stock Market News

Share This Article
Facebook Twitter Email Print
Previous Article Gold price outlook: Will yellow metal rise amid dollar-driven volatility? Experts weigh in | Stock Market News
Next Article D-Street Ahead: How will Indian stock market move next week? Your trading strategy—Key technical calls for Nifty, Sensex | Stock Market News

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS